REGENERON PHARMACEUTICALS, INC. Debt Instrument, Face Amount
REGENERON PHARMACEUTICALS, INC. (REGN) had Debt Instrument, Face Amount of $33.10 million as of 2015-09-30, per its 10-Q filed 2015-11-04.
Discontinued › Notes › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2016-02-11
- 2015-09-30: Debt Instrument, Face Amount $33.10M.
- 2015-06-30: Debt Instrument, Face Amount $33.30M.
- 2013-12-31: Debt Instrument, Face Amount $400.00M.
- 2012-09-30: Debt Instrument, Face Amount $400.00M.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2015-09-30 | $33.10M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $33.30M 10-Q · filed 2015-08-04 |
| 2013-12-31 | $400.00M 10-K · filed 2016-02-11 |
| 2012-09-30 | $400.00M 10-Q · filed 2012-10-24 |
| 2012-06-30 | $400.00M 10-Q · filed 2012-07-25 |
| 2011-10-31 | $400.00M 10-Q · filed 2015-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |